Reference data and target resolution
The organism catalogue combines species available through Ensembl with curated reference sources. Gene lookup, candidate generation, transcript handling and broad specificity are separate capabilities. A reference being available does not mean every gene or workflow has been benchmarked.
Ensembl designs use the assembly and annotation release supplied by the configured service. E. coli K-12 MG1655 uses a pinned NCBI RefSeq genomic record, NC_000913.3, associated with assembly GCF_000005845.2. Source identifiers and reference versions are retained; an unrelated strain or assembly cannot be silently substituted.
Genuine biological templates
RT-qPCR candidates are designed on retrieved spliced transcript sequences. Exons are ordered in transcriptional orientation, including on the negative strand. Concatenating intersections of exons across transcripts can create a sequence that exists in no real isoform; this application does not use that shortcut.
Genomic PCR uses the actual gene-associated genomic template. Custom mode uses the sequence supplied by the user. Template coordinates are 0-based and half-open in machine-readable records, and converted to 1-based inclusive positions where shown to readers.
Candidate generation with Primer3
The backend passes the template and explicit constraints to a separately installed primer3_core executable. Each report records its actual version and parameters. The interface does not generate oligos with a language model or substitute precomputed demonstration results.
Primer3 evaluates primer length, nearest-neighbour melting temperature, GC content, product length and configured secondary-structure constraints. The reverse primer is reported as a 5′→3′ oligonucleotide, reverse-complementary to its template binding site.
Junctions and transcript compatibility
Junction-aware design uses annotated exon boundaries on the spliced template. Requiring a junction means at least one primer must overlap a valid boundary under the recorded overlap constraints. If none can be found, the result contains no eligible pairs.
Both primers are evaluated as a pair on the retrieved transcript set, considering orientation and product size. Exact compatibility is useful evidence of coverage, but it does not establish isoform expression, exhaustively detect mismatch-supported binding or prove experimental specificity.
Thermodynamics and ranking
Predicted melting temperature depends on the nearest-neighbour model and the concentrations used for salts, dNTP and primer DNA. The report retains these assumptions. Secondary-structure values are the actual Primer3 outputs in their stated units.
When a junction is preferred, the analysis orders junction-spanning candidates first, then by Primer3 penalty. Otherwise it orders by penalty. You can explicitly sort by other metrics. A lower penalty means a closer fit to configured preferences, not a probability of assay success. Coverage, warnings and screening status remain separate.
Specificity: read the scope, not just the status
Comprehensive mismatch-aware genome and transcriptome screening is currently unavailable in this research preview. Generating candidates on a known template and searching for alternative amplification are separate calculations. The unavailable status appears in each affected report because no compatible broad screen ran; it is neither a failed primer design nor evidence of specificity.
Where configured, the bounded local reference screen searches exact paired binding sites in both orientations and checks product lengths. Such an exact-only screen is partial: it can miss amplification supported by mismatches or unrepresented sequence. The result records the scope and reference metadata.
An absence of detected alternative products is not proof that off-target amplification is impossible. Independent Primer-BLAST assessment and laboratory confirmation remain important.
What is not established
This application does not measure PCR efficiency, establish assay sensitivity, predict a measured melting curve or validate clinical use. It does not comprehensively assess sample variants, every possible contaminant or all expressed isoforms.
Appropriate wet-laboratory assessment may include no-template and no-reverse-transcription controls, product identity checks and efficiency assessment. MIQE 2.0 provides reporting guidance for qPCR experiments; using this software alone does not make an experiment MIQE-compliant.